about
Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementiaNeurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's diseaseAlzheimer's disease--a panorama glimpseGenome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.Effects of medicinal plants on Alzheimer's disease and memory deficits.Recent insights into the molecular genetics of dementiaModulation of cholesterol in midlife affords cognitive advantage during ageing - a role for altered redox balanceImpact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.Prevention of dementia: focus on lifestyle.Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease.Genetics of Alzheimer diseaseTwo rare AKAP9 variants are associated with Alzheimer's disease in African Americans.Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?Transgenic animal models of neurodegeneration based on human genetic studies.COPS5 (Jab1) protein increases β site processing of amyloid precursor protein and amyloid β peptide generation by stabilizing RanBP9 protein levels.Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorialInformed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two CasesGenetics of Vascular Dementia.Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research.White matter integrity and vulnerability to Alzheimer's disease: preliminary findings and future directions.The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.An Association Study on IL16 Gene Polymorphisms with the Risk of Sporadic Alzheimer's Disease.Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.Interactive effects of physical activity and APOE-ε4 on white matter tract diffusivity in healthy elders.Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individualsMutation-based structural modification and dynamics study of amyloid beta peptide (1-42): An in-silico-based analysis to cognize the mechanism of aggregation.Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics.Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease.Fus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory ImpairmentsClinical syndromes associated with posterior atrophy: early age at onset AD spectrum.The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease.Accuracy of reported family history and effectiveness of medical record requests in genetic counseling for Alzheimer disease.Opportunities and challenges in developing Alzheimer disease therapeutics.Meta-analysis of the association between the interleukin-1A -889C/T polymorphism and Alzheimer's disease.
P2860
Q24235058-DE64FAB3-01EE-43D4-9E3E-77D9440C6436Q26741247-2EB57880-39F2-4547-A291-792287A5C44FQ27011749-61F1A6FC-678F-4724-A16D-290F2F0BF9EDQ28602367-E4EEF197-704A-43D5-90B3-33AB8AC364F6Q33423191-F99D4264-6A6E-457D-9D64-A5EBF9446ED5Q33670207-4356863A-3101-41D7-9641-636DCF3796DFQ33702630-6E6C41F3-02E9-4BCF-9D6A-5E512CADA01CQ33830518-109D6D5E-ED1D-46CD-9558-FA0C9A9CF6F1Q33951174-E19AB0BF-09F0-4F5F-9B3C-BF328B12154DQ34032455-6977BDC8-8800-4F89-93C6-015B3B0A1BB8Q34042415-B5538406-02FE-47EF-BDDC-B9E34BB5F54EQ34284967-D10B8E06-F6E5-4E5A-9A67-21E6D3E57770Q34604101-C27AC71D-8156-4FA9-A250-6DA62AEB7E7CQ34617467-B023A92C-9BB1-4922-8FC6-891F23F3E1F8Q34814013-9039821C-56D4-46E0-BC1C-1FA9A4E59267Q34890228-74E16416-7757-4535-A90E-4FE82934E520Q34909981-FF073781-D8C8-4BAE-AE8A-76663F440401Q34974083-4314EA9B-BFEF-49A4-906D-45A3E8D2A627Q34983741-410CCC60-0503-4AED-8E3D-D01A004B2521Q35094704-22DF8232-F305-4EEA-B3C1-FF7AFE522795Q35189470-1F10ECF9-C35C-461F-BB35-7C2121078E3FQ35541822-6CA25B41-9232-489B-8725-A469610DD42DQ35599843-AC0A8311-0AA7-40D7-B5B8-8A36111153B4Q35868446-C2A96FE9-4750-40CC-8409-E74E5A7A8D25Q36481711-27EB71F4-E855-44DA-A46C-5A1E4F4A1821Q36558527-FD1B7733-13FA-4393-A4E9-0D58EF5C290AQ36600561-14FD028F-1349-48C1-BD52-BAC2849F1644Q36618909-2BE6969B-0092-4CB9-BCED-4620502BD3FBQ36652734-54F2211D-F094-4B65-B680-09A3B9DCAF26Q37191378-F8DB4269-30E8-4140-BF34-E645EC013B9EQ37204006-248E81E7-7516-42DF-8A2F-60BC7B126E2DQ37295060-621FC6E4-DF13-43AC-9709-BBE0EA1F8473Q37358548-34C63298-399C-49D2-9A80-709A402B31A8Q37413462-1ADB8B3A-FC93-4760-9190-7E2B7107ED58Q37420383-AC469D6D-BE2E-41EB-A9C8-852239FCE3B6Q37575502-80074F18-8BDE-49A8-A174-08E294BDD903Q37734864-69591CCF-F34E-401C-B22C-1EAE1B51B1BBQ37793967-B46DCC40-9D17-476E-9784-2E10D40EBF3DQ37940825-24E1A14B-38F3-40C2-B4CE-CF5670C72A01Q38003568-5E7919BB-9FFC-4160-A1FC-1A0BCE704D59
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic aspects of Alzheimer disease
@en
Genetic aspects of Alzheimer disease.
@nl
type
label
Genetic aspects of Alzheimer disease
@en
Genetic aspects of Alzheimer disease.
@nl
prefLabel
Genetic aspects of Alzheimer disease
@en
Genetic aspects of Alzheimer disease.
@nl
P2860
P1433
P1476
Genetic aspects of Alzheimer disease
@en
P2093
Thomas D Bird
P2860
P2888
P304
P356
10.1097/GIM.0B013E31816B64DC
P407
P577
2008-04-01T00:00:00Z
P5875
P6179
1039456851